26.07.2013 Views

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

immune response (Ir) genes 359 immunity to extracellular bacteria<br />

characterized by the production of chemical mediators at the<br />

site of injury. In addition to the adaptive immune response<br />

described above, animals have innate or natural immunity present<br />

from birth and designed to protect the host from injury or<br />

infection without previous contact with the infectious agent or<br />

antigen. It includes such protective factors as the skin, mucous<br />

membranes, lysozyme in tears, stomach acid, and other factors.<br />

Phagocytes, natural killer cells, and complement represent key<br />

participants in natural innate immunity. The immune response<br />

consists of a recognition stage in which the inducing agent is<br />

identified as nonself or dangerous to self and an effector stage<br />

aimed at elimination of the immunogen.<br />

immune response (Ir) genes<br />

Genes that regulate immune responsiveness to synthetic<br />

polypeptide and protein antigens as demonstrated in<br />

guinea pigs and mice. This property is transmitted as an<br />

autosomal-dominant trait that maps to the major histocompatibility<br />

complex (MHC) region. Ir genes control<br />

helper T lymphocyte activation required for the generation<br />

of antibodies against protein antigens. T lymphocytes<br />

with specific receptors for antigen fail to recognize free<br />

or soluble antigens, but they do recognize protein antigens<br />

noncovalently linked to products of MHC genes termed<br />

MHC class I and class II molecules. The failure of certain<br />

animal strains to respond may be due to ineffective antigen<br />

presentation in which processed antigen fails to bind<br />

properly to MHC class II molecules or to an ineffective<br />

interaction between the T cell receptor and the MHC class<br />

II–antigen complex.<br />

immune serum<br />

An antiserum containing antibodies specific for a particular<br />

antigen or immunogen. Such antibodies may confer protective<br />

immunity.<br />

immune serum globulin<br />

Injectable immunoglobulin that consists mainly of IgG<br />

extracted by cold ethanol fractionation from pooled plasma<br />

from up to 1000 human donors. It is administered as a sterile<br />

16.5 ± 1.5% solution to patients with immunodeficiencies<br />

and as a preventive against certain viral infections including<br />

measles and hepatitis A.<br />

immune stimulatory complexes<br />

Refer to ISCOMs.<br />

immune suppression<br />

Decreased immune responsiveness as a consequence of therapeutic<br />

intervention with drugs or irradiation or arising from<br />

a disease process that adversely affects the immune response,<br />

such as acquired immune deficiency syndrome (AIDS).<br />

immune surveillance<br />

The policing function of immune system cells to identify<br />

and destroy clones of transformed cells prior to their development<br />

into neoplasms and to destroy tumors after they<br />

develop. Indirect evidence for this concept has included<br />

observations that the incidence of neoplasia increases<br />

with age-associated decrease in immune competence, the<br />

development of tumors in T cell-deficient subjects, and<br />

increased incidence of tumor development in deliberately<br />

immunosuppressed individuals, such as those receiving<br />

organ allotransplants.<br />

immune system<br />

The molecules, cells, tissues, and organs associated with<br />

adaptive immunity, such as the host defense mechanisms,<br />

mainly against infectious agents.<br />

Microorganism Cell Type<br />

Extracellular bacteria Polymorphonuclear<br />

neutrophils (PMNs)<br />

Parasites<br />

Eosinophils<br />

Intracellular<br />

Macrophages<br />

microorganisms<br />

(i.e., mycobacteria or<br />

fungi)<br />

Viruses<br />

Lymphocytes, NK cells<br />

Nonspecific cellular defense.<br />

immune system anatomy<br />

The lymphocyte is the cell responsible for immune response<br />

specificity. The human mature lymphoid system is comprised<br />

of 2 × 10 12 lymphocytes and various accessory cells that<br />

include epithelial cells, monocytes/macrophages, and other<br />

antigen-presenting cells. Accessory cells are requisite for<br />

both maturation and effector functions of lymphocytes. The<br />

thymus is the site of maturation of T cells, and the bone marrow<br />

is the maturation site of B cells. These two tissues comprise<br />

the primary lymphoid organs. The secondary lymphoid<br />

organs consist of the cervical lymph nodes, ancillary lymph<br />

nodes, spleen, mesenteric lymph nodes, and inguinal lymph<br />

nodes. Mature lymphocytes migrate from the central lymphoid<br />

organs by way of the blood vessels to the secondary or<br />

peripheral tissues and organs, where they respond to antigen.<br />

Peripheral lymphoid tissues comprise the spleen and lymph<br />

nodes and mucosa-associated lymphoid tissue (MALT)<br />

associated with the respiratory, genitourinary, and gastrointestinal<br />

tracts making up 50% of the lymphoid cells of the<br />

body. MALT consists of the adenoids, tonsils, and mucosaassociated<br />

lymphoid cells of the respiratory, genitourinary,<br />

and gastrointestinal tracts, and Peyer’s patches in the gut.<br />

immune tolerance<br />

Refer to immunologic tolerance.<br />

immunity<br />

Acquired or innate resistance or protection from a pathogenic<br />

microorganism or its products or from the effects of<br />

toxic substances such as snake or insect venom.<br />

immunity deficiency syndrome<br />

Synonym for immunodeficiency.<br />

immunity in prokaryotes<br />

Numerous antimicrobial agents synthesized and released<br />

extracellularly by bacteria exert specific effects on bacteria.<br />

They include (1) enzymatically synthesized antibiotics,<br />

(2) post-translationally modified peptide antibiotics, (3)<br />

protein antibiotics such as bacteriocins, protein exotoxins,<br />

and bacteriolytic enzymes, and (4) intemperate or temperate<br />

bacterial viruses. Once these agents are inside bacterial<br />

cells they must remain unchanged to exert their actions.<br />

Bacteriocins released by bacteria may inhibit the growth of<br />

other sensitive closely related bacteria. The strain producing<br />

the bacteriocin is usually able to resist its effect through<br />

specific immunity peptides or proteins.<br />

immunity to extracellular bacteria<br />

Neutrophil (PMN), monocyte, and tissue macrophage<br />

phagocytosis leads to rapid microbial action against ingested<br />

microbes from the extracellular environment. The capacity<br />

of a microorganism to resist phagocytosis and digestion<br />

in phagocytic cells is a principal feature of its virulence.<br />

I

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!